For Bisphosphonates, What Kind Of News Is No News?
This article was originally published in The Pink Sheet Daily
Executive Summary
After latest studies suggesting a possible link between bisphosphonates and fractures are presented at a medical meeting, FDA emphasizes that its investigation is continuing.
You may also be interested in...
Bisphosphonates Might Get Limits On Treatment Duration Following Label Change
Accumulating data on femur fractures lead FDA to consider telling physicians to take patients off the drug at least temporarily when bone mineral density targets are reached.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.